Jamie Christensen - Dec 18, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
EVP & Chief Scientific Officer
Signature
/s/ John Moriarty, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Dec 18, 2023
Transactions value $
-$137,253
Form type
4
Date filed
12/19/2023, 04:59 PM
Previous filing
Sep 12, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale -$137K -2.39K -1.66% $57.50 142K Dec 18, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021.